Liam Ratcliffe's Net Worth

$275 Million

Who is Liam Ratcliffe?

Liam Ratcliffe has an estimated net worth of $275 Million. This is based on reported shares across multiple companies, which include Relypsa Inc, Eliem Therapeutics, Inc., Deciphera Pharmaceuticals, Inc., iRhythm Technologies, Inc., Unum Therapeutics Inc., ARVINAS, INC., Oxford Immunotec Global PLC, CONCERT PHARMACEUTICALS, INC., Edge Therapeutics, Inc., Iterum Therapeutics plc, Passage BIO, Inc., Durata Therapeutics, Inc., Aptinyx Inc., Versartis, Inc., CHIMERIX INC, Disc Medicine, Inc., ARRAY BIOPHARMA INC, and MEI Pharma, Inc..

SEC CIK

Liam Ratcliffe's CIK is 0001547100

Past Insider Trading and Trends

2018 was Liam Ratcliffe's most active year for acquiring shares with 24 total transactions. Liam Ratcliffe's most active month to acquire stocks was the month of September. 2021 was Liam Ratcliffe's most active year for disposing of shares, totalling 41 transactions. Liam Ratcliffe's most active month to dispose stocks was the month of October. 2019 saw Liam Ratcliffe paying a total of $15,009,372.94 for 724,616 shares, this is the most they've acquired in one year. In 2014 Liam Ratcliffe cashed out on 43,616,842 shares for a total of $19,074,752.54, their largest year based on trade value.